ADAR1 Capital Management, LLC
Follow13F filer, CIK 1940272, AUSTIN, TX
ADAR1 Capital Management, LLC reported $500,371,182 across 214 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-13. Its ten largest share positions make up 49.77% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001940272-25-000001
- Period
- 2024-12-31
- Reported value
- $500M
- Holdings
- 214
- Top 10 weight
- 49.77%
- New
- 53
- Sold out
- 117
Stakes and trades reported after 2024-12-31
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- INM INMED PHARMACEUTICALS INC: Form 4 bought 984 shares on 2026-10-15, 0001940272-26-000025Timeline
Accepted , ingested - INM INMED PHARMACEUTICALS INC: Form 4 bought 8,021 shares on 2026-10-14, 0001940272-26-000025Timeline
Accepted , ingested - INM INMED PHARMACEUTICALS INC: Form 4 bought 564 shares on 2026-10-13, 0001940272-26-000025Timeline
Accepted , ingested
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IKTnew | +5,103,005 | $16.6M |
| ZLABadded | +513,383 | $13.4M |
| BILadded | +110,000 | $10.1M |
| ABVXadded | +991,781 | $7.26M |
| AVRnew | +1,052,968 | $5.88M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RPRXreduced | -1,046,703 | -$26.7M |
| CYTKreduced | -496,973 | -$23.4M |
| BBIOreduced | -769,613 | -$21.1M |
| ASNDreduced | -90,000 | -$12.4M |
| IMVTreduced | -344,229 | -$8.53M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Back to all 195 share positions
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| PTGXPROTAGONIST THERAPEUTICS INC COM | call | 132,000 | $5.1M | new |
| XBISPDR SERIES TRUST S&P BIOTECH | call | 50,000 | $4.5M | new |
| JNJJOHNSON & JOHNSON COM | call | 10,000 | $1.45M | new |
| CAPRCAPRICOR THERAPEUTICS INC COMMON STOCK | call | 95,000 | $1.31M | new |
| CYTKCYTOKINETICS INC COM NEW | call | 15,100 | $710K | 0 |
| AKROAKERO THERAPEUTICS INC COM | call | 22,500 | $626K | 0 |
| Applied Therapeutics IncApplied Therapeutics Inc Common Stock | call | 530,324 | $454K | +124 |
| BMRNBIOMARIN PHARMACEUTICAL INC COM | call | 5,000 | $329K | 0 |
| TARSTARSUS PHARMACEUTICALS INC COMMON STOCK | call | 5,000 | $277K | 0 |
| RGNXREGENXBIO INC COM | call | 17,800 | $138K | 0 |
| PHATPHATHOM PHARMACEUTICALS INC COMMON STOCK | call | 10,100 | $82K | new |
| CRVSCORVUS PHARMACEUTICALS INC COM | put | 15,000 | $80.2K | new |
| CRVSCORVUS PHARMACEUTICALS INC COM | call | 10,000 | $53.5K | new |
| AMLXAMYLYX PHARMACEUTICALS INC COM | call | 10,000 | $37.8K | 0 |
| GOSSGOSSAMER BIO INC Stock | call | 19,898 | $18K | -102 |
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| COHERUS ONCOLOGY INCCOHERUS ONCOLOGY INC BOND | principal | 5,625,000 | $5.48M | new |
| GOSSAMER BIO INCGOSSAMER BIO INC NOTE 5.000% 6/0 | principal | 8,000,000 | $4.36M | new |
| BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC Convertible | principal | 4,500,000 | $3.86M | new |
| BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC NOTE 2.500% 3/1 | principal | 2,000,000 | $2.1M | new |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| SNDXSYNDAX PHARMACEUTICALS INC | 350,206 | $6.74M | shares |
| XBISPDR SERIES TRUST | 40,000 | $3.95M | put |
| QTTBQ32 BIO INC | 64,245 | $2.87M | shares |
| PIERIS PHARMACEUTICALS INCPIERIS PHARMACEUTICALS INC | 144,641 | $2.4M | shares |
| NVONOVO-NORDISK A S | 20,000 | $2.38M | put |
| SNDXSYNDAX PHARMACEUTICALS INC | 105,000 | $2.02M | call |
| MCKMCKESSON CORP | 3,000 | $1.48M | call |
| NVONOVO-NORDISK A S | 10,000 | $1.19M | call |
| BNTXBIONTECH SE | 10,000 | $1.19M | shares |
| ENVVENO MEDICAL CORPORATIONENVVENO MEDICAL CORPORATION | 348,263 | $1.17M | shares |
| PCVXVAXCYTE INC | 10,097 | $1.15M | shares |
| NUVLNUVALENT INC | 10,442 | $1.07M | shares |
| AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALS | 80,900 | $1.06M | shares |
| BCAXBICARA THERAPEUTICS INC | 40,440 | $1.03M | shares |
| INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INC | 13,400 | $980K | shares |
| AGIOAGIOS PHARMACEUTICALS INC | 21,300 | $946K | shares |
| REVANCE THERAPEUTICS INCREVANCE THERAPEUTICS INC | 182,166 | $945K | shares |
| MIRMMIRUM PHARMACEUTICALS INC | 24,100 | $940K | shares |
| MCKMCKESSON CORP | 1,850 | $915K | shares |
| CGEMCULLINAN THERAPEUTICS INC | 54,358 | $910K | shares |
| TARSTARSUS PHARMACEUTICALS INC | 25,900 | $852K | shares |
| AVANGRID INCAVANGRID INC | 23,000 | $823K | shares |
| AMLXAMYLYX PHARMACEUTICALS INC | 220,906 | $716K | shares |
| POWERSCHOOL HOLDINGS INCPOWERSCHOOL HOLDINGS INC | 30,000 | $684K | shares |
| AURAAURA BIOSCIENCES INC | 73,663 | $656K | shares |
| OPCHOPTION CARE HEALTH INC | 20,000 | $626K | shares |
| KURAKURA ONCOLOGY INC | 30,000 | $586K | shares |
| TMT ACQUISITION CORPTMT ACQUISITION CORP | 50,000 | $562K | shares |
| MASIMASIMO CORP | 3,894 | $519K | shares |
| THTARGET HOSPITALITY CORP | 65,741 | $511K | shares |
| ARVNARVINAS INC | 20,400 | $502K | shares |
| EWTXEDGEWISE THERAPEUTICS INC | 18,178 | $485K | shares |
| BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP | 5,100 | $472K | shares |
| BIOMX INCBIOMX INC | 432,700 | $441K | shares |
| SYRESPYRE THERAPEUTICS INC | 12,560 | $369K | shares |
| ACADACADIA PHARMACEUTICALS INC | 23,100 | $355K | shares |
| TXG10X GENOMICS INC | 15,000 | $339K | shares |
| OAK WOODS ACQUISITION CORP-AOAK WOODS ACQUISITION CORP-A | 30,000 | $333K | shares |
| JSPRJASPER THERAPEUTICS INC | 15,816 | $297K | shares |
| IMVTIMMUNOVANT INC | 10,200 | $291K | call |
| Tourmaline Bio IncTourmaline Bio Inc | 11,260 | $289K | shares |
| VYNEVYNE THERAPEUTICS INC | 152,865 | $287K | shares |
| ORKAORUKA THERAPEUTICS INC | 11,187 | $274K | shares |
| BSXBOSTON SCIENTIFIC CORP | 2,500 | $210K | shares |
| TERNTERNS PHARMACEUTICALS INC | 24,702 | $206K | shares |
| CLDXCELLDEX THERAPEUTICS INC NEW | 5,000 | $170K | shares |
| NUVEI CORPORATIONNUVEI CORPORATION | 5,000 | $167K | shares |
| ABEOABEONA THERAPEUTICS INC | 24,322 | $154K | shares |
| GALTGALECTIN THERAPEUTICS INC | 55,300 | $152K | put |
| PROPERTYGURU GROUP LTDPROPERTYGURU GROUP LTD | 20,000 | $132K | shares |
| BHVNBIOHAVEN LTD | 2,637 | $132K | shares |
| PERIMETER SOLUTIONS SAPERIMETER SOLUTIONS SA | 9,000 | $121K | shares |
| TGTXTG THERAPEUTICS INC | 5,000 | $117K | shares |
| BEYOND AIR INCBEYOND AIR INC | 282,131 | $109K | shares |
| ACRSACLARIS THERAPEUTICS INC | 90,000 | $104K | shares |
| ANIPANI PHARMACEUTICALS INC | 1,700 | $101K | shares |
| SYRSSYROS PHARMACEUTICALS INC COM | 45,000 | $96.8K | shares |
| LQDALIQUIDIA CORPORATION | 9,285 | $92.8K | shares |
| ESTAESTABLISHMENT LABS HLDGS INC | 2,000 | $86.5K | shares |
| BMRNBIOMARIN PHARMACEUTICAL INC | 1,200 | $84.3K | shares |
| CRBPCORBUS PHARMACEUTICALS HLDGS | 4,000 | $82.5K | shares |
| AI Transportation Acquisiti…AI Transportation Acquisition Corp | 7,500 | $78.6K | shares |
| IKENA ONCOLOGY INCIKENA ONCOLOGY INC | 44,635 | $77.2K | shares |
| Applied Therapeutics IncApplied Therapeutics Inc | 8,727 | $74.2K | shares |
| ITERIS INC NEWITERIS INC NEW | 10,000 | $71.4K | shares |
| SAGE THERAPEUTICS INCSAGE THERAPEUTICS INC | 9,500 | $68.6K | call |
| FDMT4D MOLECULAR THERAPEUTICS IN | 6,000 | $64.9K | shares |
| CVSCVS HEALTH CORP | 1,000 | $62.9K | shares |
| PRTCYPURETECH HEALTH PLC | 3,000 | $61.8K | shares |
| GRALGRAIL INC | 4,401 | $60.6K | shares |
| WSTWEST PHARMACEUTICAL SVSC INC | 200 | $60K | shares |
| GLREGREENLIGHT CAP RE LTD | 4,385 | $59.9K | shares |
| ARGXARGENX SE | 110 | $59.6K | shares |
| TRIPTRIPADVISOR INC | 4,000 | $58K | shares |
| AZNASTRAZENECA PLC-SPONS ADR | 700 | $54.5K | shares |
| FULCFULCRUM THERAPEUTICS INC | 15,000 | $53.5K | call |
| CARA THERAPEUTICS INCCARA THERAPEUTICS INC | 159,469 | $49.1K | shares |
| DIREXION SHS ETF TRDIREXION SHS ETF TR | 8,400 | $49.1K | shares |
| FIBROGEN INCFIBROGEN INC | 120,663 | $48.2K | shares |
| NORDSTROM INCNORDSTROM INC | 2,000 | $45K | shares |
| CELCCELCUITY INC | 3,000 | $44.7K | shares |
| MISTMILESTONE PHARMACEUTICALS IN | 27,931 | $42.5K | shares |
| UCTTULTRA CLEAN HLDGS INC | 1,000 | $39.9K | shares |
| LUMOS PHARMA INCLUMOS PHARMA INC | 10,000 | $38.7K | shares |
| PHVSPHARVARIS N V | 2,000 | $37K | shares |
| FBRXFORTE BIOSCIENCES INC | 6,000 | $33.5K | shares |
| IDYAIDEAYA BIOSCIENCES INC | 1,000 | $31.7K | shares |
| BHCBAUSCH HEALTH COS INC | 3,700 | $30.2K | shares |
| NATLNCR ATLEOS CORPORATION | 1,000 | $28.5K | shares |
| IONSIONIS PHARMACEUTICALS INC | 700 | $28K | shares |
| RNAMAVIDITY BIOSCIENCES INC | 600 | $27.6K | shares |
| VYXNCR VOYIX CORPORATION | 2,000 | $27.1K | shares |
| PRGOPERRIGO CO PLC | 1,000 | $26.2K | shares |
| TGTXTG THERAPEUTICS INC | 1,000 | $23.4K | put |
| NGNENEUROGENE INC | 553 | $23.2K | shares |
| KRYSKRYSTAL BIOTECH INC | 100 | $18.2K | shares |
| KROSKEROS THERAPEUTICS INC | 300 | $17.4K | call |
| NTLAINTELLIA THERAPEUTICS INC | 800 | $16.4K | shares |
| EYPTEYEPOINT INC | 2,000 | $16K | shares |
| DYNDYNE THERAPEUTICS INC | 400 | $14.4K | shares |
| ENGNENGENE HOLDINGS INC | 1,970 | $13K | shares |
| BLCOBAUSCH PLUS LOMB CORP | 600 | $11.6K | shares |
| MDGLMADRIGAL PHARMACEUTICALS INC | 50 | $10.6K | shares |
| TMT ACQUISITION CORPTMT ACQUISITION CORP | 37,100 | $10.1K | shares |
| ADXNADDEX THERAPEUTICS LTD | 1,000 | $9.77K | shares |
| INTELLIGENT BIO SOLUTIONS ININTELLIGENT BIO SOLUTIONS IN | 5,389 | $9.32K | shares |
| OKLOOKLO INC | 1,000 | $8.09K | shares |
| MRKRMARKER THERAPEUTICS INC | 2,432 | $6.86K | shares |
| EQEQUILLIUM INC | 7,318 | $6.09K | shares |
| MRVIMARAVAI LIFESCIENCES HLDGS I | 700 | $5.82K | shares |
| BKHARBLACK HAWK ACQUISITION CORP | 3,000 | $3.48K | shares |
| ICHRICHOR HOLDINGS | 108 | $3.44K | shares |
| SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC | 100 | $3.2K | shares |
| MITKMITEK SYS INC | 200 | $1.73K | shares |
| AI TRANSPORTATION ACQUIS-RTSAI TRANSPORTATION ACQUIS-RTS | 7,500 | $1.27K | shares |
| ANROALTO NEUROSCIENCE INC | 100 | $1.14K | put |
| MKDWWMKDWELL TECH INC | 3,270 | $60 | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001940272-25-000001 | base | 2025-02-13 | acceptance time not in the bulk data set |